Lab-on-Skin to Detect Sepsis Before It's Too Late: Esmeralda Megally, Xsensio

If you suddenly slide into sepsis, there’s a 50% chance you’ll survive. Because it is so hard to detect it.Lab-on-Skin works to change it. And has the Mayo Clinic on their side.Today you’ll hear aboutcontinuous shock monitoring – to detect the earliest symptoms of sepsishow to assess sepsisnanotechnology, nanoelectronics, nanofluidicsand the unexplored wealth of our interstitial fluidEsmeralda Megally is the CEO and co-founder of Xsensio. Having worked in the US on the launch of a new Investment Fund backed by the Bill & Melinda Gates Foundation, she found her entrepreneurship call in Switzerland.Xsensio is a Swiss startup, a spinoff from the Nanolab at EPFL that develops Lab-on-Skin. It’s a medical-grade wearable that tracks biochemical information for continuous remote monitoring of patients at risk – sepsis for the start. But there's way more to come, so keep an eye on them:https://xsensio.com/Timestamps:0:00 Esmeralda Megally and Xsensio1:09 Septic Shock Poor Survival Rate4:50 How to Recognize Sepsis8:20 Lab-on-Skin to Measure Biomarkers in Interstitial Fluid17:34 Continuous Shock Monitoring21:01 What Is Interstitial Fluid24:24 Team and Collaborations: Mayo Clinic, CHUV32:39 How Does Lab-on-Skin Work43:08 The Future of Continuous Monitoring46:34 Thank You, Follow Xsensio47:23 Follow X-Health.show, Disclaimer If you've enjoyed listening, you'll make us happy by clicking "Follow" on X-Health.show and leaving a review.The information in this podcast is for informational purposes only and should not be considered medical advice. If you have any medical questions, please consult your healthcare practitioner. The opinions on the show are Alex's or her guests. The podcast does not make any responsibility or warranties about guests statements or credibility. While the podcast makes every effort to ensure that the information shared is accurate, please let us know if you have any comments, suggestions or corrections.